retatrutide make you tired VisualAbstract: reduces body weight by 17.5% in patients with obesity What to Know About Retatrutide

The problem is obesity is categorised per BMI which is based on weight but by definition obesity is about excess adiposity and not weight

This isnt speculative

Still, burping is not the most common side effect of Wegovy, according to the drug label

In trials, users achieved up to ~24% body-weight reduction over 48 weeks, plus improvements in fat-to-lean mass ratio, insulin sensitivity, and metabolic markers

3.3.4 Polyethylene glycol loxenatide The early GLP-1R agonist has many defects, such as multiple injections and a high incidence of adverse reactions in the digestive tract, which limits its clinical application

This is why having the correct bac water ratio for retatrutide is so essential